{"id":"https://openalex.org/W7202185656","doi":"https://doi.org/10.1093/jac/dkag280","title":"Differential salivary disposition of linezolid and its two major metabolites (PNU-142300 and PNU-142586) after a single dose in healthy adults","display_name":"Differential salivary disposition of linezolid and its two major metabolites (PNU-142300 and PNU-142586) after a single dose in healthy adults","publication_year":2026,"publication_date":"2026-08-04","ids":{"openalex":"https://openalex.org/W7202185656","doi":"https://doi.org/10.1093/jac/dkag280","pmid":"https://pubmed.ncbi.nlm.nih.gov/42576790"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkag280","doi":"https://doi.org/10.1093/jac/dkag280","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkag280","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072966421","display_name":"Yasuhiro Tsuji","orcid":"https://orcid.org/0000-0002-7967-2947","observed_orcids":["https://orcid.org/0000-0002-7967-2947"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Tsuji","raw_affiliation_strings":["Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":"https://orcid.org/0000-0002-7967-2947","affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023066502","display_name":"Hitoshi Kawasuji","orcid":"https://orcid.org/0000-0002-5536-101X","observed_orcids":["https://orcid.org/0000-0002-5536-101X"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kawasuji","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,"],"raw_orcid":"https://orcid.org/0000-0002-5536-101X","affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125385031","display_name":"Tomona YAMADA","orcid":"https://orcid.org/0009-0002-1370-4202","observed_orcids":["https://orcid.org/0009-0002-1370-4202"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomona Yamada","raw_affiliation_strings":["Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":"https://orcid.org/0009-0002-1370-4202","affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013792985","display_name":"Fumihiro Kurosaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumihiro Kurosaki","raw_affiliation_strings":["Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111697530","display_name":"Naoki Oikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Oikawa","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, School of Pharmacy, Nihon University , 7-7-1, Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, School of Pharmacy, Nihon University , 7-7-1, Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039788766","display_name":"Makito Kaneda","orcid":"https://orcid.org/0009-0004-3156-2716","observed_orcids":["https://orcid.org/0009-0004-3156-2716"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makito Kaneda","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088440964","display_name":"Takahiko Aoyama","orcid":"https://orcid.org/0000-0001-6111-8537","observed_orcids":["https://orcid.org/0000-0001-6111-8537"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiko Aoyama","raw_affiliation_strings":["Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University , 7-7-1 Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043284894","display_name":"Taketo Uchiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taketo Uchiyama","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, School of Pharmacy, Nihon University , 7-7-1, Narashinodai, Funabashi, Chiba 274-8555 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, School of Pharmacy, Nihon University , 7-7-1, Narashinodai, Funabashi, Chiba 274-8555 ,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087903422","display_name":"Yoshihiro Yamamoto","orcid":"https://orcid.org/0000-0003-2088-8724","observed_orcids":["https://orcid.org/0000-0003-2088-8724"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Yamamoto","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,"],"raw_orcid":"https://orcid.org/0000-0003-2088-8724","affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences , 2630 Sugitani, Toyama, Toyama 930-0194 ,","institution_ids":["https://openalex.org/I42766147"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"9","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.017100000753998756,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":1.0},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/single-intravenous-dose","display_name":"single intravenous dose","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.9100000262260437},{"id":"https://openalex.org/C504460877","wikidata":"https://www.wikidata.org/wiki/Q155925","display_name":"Saliva","level":2,"score":0.8999999761581421},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8550999760627747},{"id":"https://openalex.org/C38022665","wikidata":"https://www.wikidata.org/wiki/Q1149305","display_name":"Disposition","level":2,"score":0.6826000213623047},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6298999786376953},{"id":"https://openalex.org/C2988731192","wikidata":"https://www.wikidata.org/wiki/Q7410159","display_name":"Blood sampling","level":2,"score":0.6189000010490417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5848000049591064},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.4851999878883362},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4498000144958496},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4253999888896942},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.3693999946117401},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3003000020980835},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2759000062942505},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.27160000801086426},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.2660999894142151},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.26600000262260437},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.2596000134944916}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012463","descriptor_name":"Saliva","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/dkag280","doi":"https://doi.org/10.1093/jac/dkag280","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkag280","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:42576790","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42576790","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G5494636825","display_name":"Creation of a non-invasive TDM for anti-MRSA drugs using drug concentration in saliva as a new index","funder_award_id":"22K08597","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320309995","display_name":"Nihon University","ror":"https://ror.org/05jk51a88"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1527218782","https://openalex.org/W2102329750","https://openalex.org/W2118901469","https://openalex.org/W2147238867","https://openalex.org/W2313968233","https://openalex.org/W2586337928","https://openalex.org/W3000917839","https://openalex.org/W3011556549","https://openalex.org/W3132361882","https://openalex.org/W3160365151","https://openalex.org/W4381470521","https://openalex.org/W4382182129","https://openalex.org/W4412157409","https://openalex.org/W4416159588","https://openalex.org/W4416903819","https://openalex.org/W7128371551"],"related_works":["https://openalex.org/W4403289820","https://openalex.org/W7204519326","https://openalex.org/W7164994425","https://openalex.org/W7128371551","https://openalex.org/W3135970820","https://openalex.org/W7144529008","https://openalex.org/W1527218782","https://openalex.org/W2099446110","https://openalex.org/W2398624152","https://openalex.org/W2161181970"],"abstract_inverted_index":{"BACKGROUND:":[0],"Salivary":[1,181],"therapeutic":[2],"drug":[3,177],"monitoring":[4],"of":[5,26,49,70,89,122,140],"linezolid":[6,30,90,157,190],"has":[7],"been":[8,37],"proposed":[9],"as":[10],"a":[11,66],"non-invasive":[12],"alternative":[13],"to":[14,189,197],"blood":[15,73,133],"sampling":[16,149],"for":[17,79,174],"pharmacokinetic":[18,54],"assessment.":[19],"However,":[20],"the":[21,27,42,137,154,175,192,212],"salivary":[22,43,116,171],"disposition":[23,44,172],"and":[24,33,45,51,74,86,91,97,114,127,178,199,207],"pharmacokinetics":[25],"two":[28,93,164],"major":[29,94,165],"metabolites,":[31,95],"PNU-142300":[32,50,96,126,198],"PNU-142586,":[34,98],"have":[35],"not":[36,202],"characterized.":[38],"OBJECTIVE:":[39],"To":[40],"evaluate":[41],"serum":[46,124,187],"protein":[47],"binding":[48],"PNU-142586":[52,128,200],"using":[53,101,205],"analysis.":[55],"METHODS:":[56],"In":[57],"this":[58],"exploratory":[59],"study,":[60],"six":[61],"healthy":[62],"adult":[63],"volunteers":[64],"received":[65],"single":[67],"intravenous":[68],"dose":[69],"linezolid.":[71],"Serial":[72],"saliva":[75,143,206],"samples":[76],"were":[77,99,129,167,183],"collected":[78],"10":[80],"h":[81],"after":[82],"dosing.":[83],"The":[84],"total":[85],"protein-unbound":[87,123,186],"concentrations":[88,182],"its":[92,115,163,179],"quantified":[100],"validated":[102],"high-performance":[103],"liquid":[104],"chromatography":[105],"methods.":[106],"RESULTS:":[107],"Linezolid":[108],"was":[109,158],"consistently":[110],"quantifiable":[111,131,159],"in":[112,132,142,144,160,211],"saliva,":[113,161],"concentration-time":[117],"profile":[118],"closely":[119],"followed":[120],"that":[121],"exposure.":[125],"readily":[130],"but":[134],"remained":[135],"below":[136],"lower":[138],"limit":[139],"quantification":[141],"all":[145,148],"participants":[146],"at":[147],"time":[150],"points.":[151],"CONCLUSIONS:":[152],"Under":[153],"conditions":[155,193],"studied,":[156,194],"whereas":[162,195],"metabolites":[166],"not,":[168],"indicating":[169],"different":[170],"profiles":[173],"parent":[176],"metabolites.":[180],"consistent":[184],"with":[185],"exposure":[188,196],"under":[191],"could":[201],"be":[203],"assessed":[204],"required":[208],"blood-based":[209],"measurements":[210],"present":[213],"study.":[214]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-12T00:00:00"}